Autoimmune/Cholestatic/Biliary Diseases

Top Story

6 autoimmune liver disease stories on cholangitis risks, outcomes

September 17, 2018
In the Journals

Adverse events, liver failure common after ERCP in cirrhosis

September 7, 2018
Adverse events occurred more often among patients with cirrhosis than noncirrhotic cases after endoscopic retrograde cholangiopancreatography and correlated with a…
In the Journals

MRI biomarker identifies clinical endpoints in PSC

August 30, 2018
Researchers identified a potential prognostic biomarker for patients with primary sclerosing cholangitis using magnetic imaging resonance-measured relative enhancement…
FDA News

FDA approves Mulpleta for thrombocytopenia in adults with chronic liver disease

July 31, 2018
The FDA approved lusutrombopag for the treatment of thrombocytopenia among adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. …
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Chapter 6: Nutrients To Nourish The Organisms: Prebiotics And Fiber

From Probiotics: A Clinical Guide
More »
Resource Centers
International Liver Congress

International Liver Congress

Meeting News

VIDEO: Education needed to differentiate between PBC, PSC

November 14, 2016
More »